Senior Analyst, Analytical and Quality Control

Blue Rock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENE™ platform, we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases. Founded in 2016, Blue Rock is at the forefront of the convergence of cell biology and genetic engineering.

Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.

What Are We Doing? Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies. We are passionate about realizing the promise of cell and gene therapy, shaping the future of regenerative medicine, and delivering new therapies to patients with limited or no treatment options.

Blue Rock Therapeutics LP is a clinical stage cell therapy company harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. Blue Rock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer.

Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.

What Are We Doing? Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.

We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.

We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients’ lives.

The Senior Analyst, Analytical and Quality Control will support the GMP testing requirements of cell-based therapeutics destined for human clinical trials, from starting materials to final differentiated cell therapy. The Senior Analyst will ensure that QC Test methods are executed in a GMP compliant manner for samples generated by Manufacturing, as well as raw Materials, intermediates, final drug product and through to doses prepared for the clinic.

Additionally, the analyst will execute characterization and non-GMP tests to support cell therapies process characterization. Additional duties will include writing and reviewing Standard Operating Procedures (SOPs) related to QC functions, and coordinating the revision, review, and approval of SOPs and other GMP documents that are necessary for ensuring testing is compliant with applicable U.S., Canadian and global standards.

• Perform and/or support QC testing activities for samples generated for release testing and compliance of cell therapies…